家用输液治疗市场、机会、成长动力、产业趋势分析与预测，2024-2032

Home Infusion Therapy Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年07月12日 | 出版商:

Global Market Insights Inc. | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

简介目录

由于慢性病盛行率上升和人口老化，家庭输液治疗市场规模预计 2024 年至 2032 年复合年增长率将达到 11%。报告表明，大约三分之一的成年人患有多种慢性病。随着糖尿病、癌症和心血管问题等疾病的日益流行，对持续和客製化治疗解决方案的需求不断增加。居家输液治疗为患者在家中接受基本药物和治疗提供了一种方便有效的方法，最大限度地减少了频繁去医院的必要性。

输液技术的最新进展，特别是便携式和用户友好型输液泵，彻底改变了家庭药物管理。此外，专业输液服务的不断增加，加上专业的医疗保健支持，增强了居家输液治疗的安全性和可行性。

整个产业分为产品、应用、区域。

从产品来看，无针连接器领域的家庭输液治疗市场预计从 2024 年到 2032 年将出现显着的复合年增长率，因为它们能够提高安全性和易用性。透过在给药过程中消除针头，无针连接器大大降低了针刺伤害和感染的风险，这在家庭护理环境中是一个至关重要的优势。它们的使用者友善性确保了更顺畅、更卫生的用药管理，从而提高患者的舒适度和对治疗方案的依从性。

水化疗法应用领域的家庭输液疗法市场价值预计将从 2024 年到 2032 年上升。水合疗法越来越多地在家中进行，以提高患者的舒适度和便利性。

预计亚太地区家庭输液治疗产业将在 2024 年至 2032 年间呈现利润丰厚的成长。随着糖尿病、癌症和心血管疾病等疾病在该地区日益突出，对家庭治疗解决方案的需求也随之增加。

产业生态系统分析
产业影响力
- 成长动力
  - 院内感染不断增加
  - 慢性病盛行率上升
  - 技术进步
  - 老年人口不断增加
  - 人们越来越偏好家庭医疗保健解决方案
- 产业陷阱与挑战
  - 缺乏报销
  - 与家用输液装置相关的安全问题和故障风险
成长潜力分析
监管环境
家庭输液治疗行业趋势
差距分析
波特的分析
PESTEL分析
家庭输液治疗产业未来前景

第 4 章：竞争格局

介绍
公司矩阵分析
公司市占率分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

主要趋势
点滴帮浦
静脉注射套
静脉插管
无针头连接器

第 6 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
抗感染
水合疗法
化疗
肠内营养
肠外营养
特种药品
其他应用

第 7 章：市场估计与预测：按地区划分，2021 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 8 章：公司简介

AMERITA INC.
Amsino International, Inc.
B. Braun Melsungen AG
Baxter International Inc.
Becton Dickinson and Company
Contec Medical Systems Co. Ltd
Erenler Medikal
Fresenius Kabi
Halyard Health, Inc. (Avanos Medical)
ICU Medical Inc.
JMS Co. Ltd.
Lepu Medical Technology
Moog Inc.
Option Care Health, Inc.
Terumo Corporation

简介目录

Product Code: 435

Home infusion therapy market size is anticipated to record an 11% CAGR from 2024 to 2032 led by the rising prevalence of chronic diseases and an aging population. Reports indicate that approximately one in three adults grapple with multiple chronic conditions. With the increasing prevalence of diseases like diabetes, cancer, and cardiovascular issues, there is a heightened demand for continuous and tailored treatment solutions. Home infusion therapy provides a convenient and effective means for patients to receive essential medications and treatments right at home, minimizing the necessity for frequent hospital visits.

Recent advancements in infusion technology, particularly portable and user-friendly infusion pumps, have revolutionized medication management at home. Furthermore, the growing availability of specialized infusion services, coupled with professional healthcare support, bolsters the safety and feasibility of home infusion therapy.

The overall industry is divided into product, application, and region.

Based on product, the home infusion therapy market from the needleless connectors segment is expected to record a significant CAGR from 2024 to 2032 due to their ability to enhance safety and ease of use. By eliminating needles during medication administration, needleless connectors drastically lower the risk of needle-stick injuries and infections, a crucial advantage in home care settings. Their user-friendly nature ensures smoother, more hygienic medication administration, thereby enhancing patient comfort and adherence to treatment protocols.

Home infusion therapy market value from the hydration therapy application segment is projected to rise from 2024 to 2032. This is owing to its essential role in managing dehydration and supporting patients with chronic conditions or undergoing intensive treatments. Hydration therapy is increasingly being provided at home to improve patient comfort and convenience.

Asia Pacific home infusion therapy industry is projected to exhibit lucrative growth between 2024 and 2032. This surge is driven by a rising prevalence of chronic diseases, an expanding elderly demographic, and notable advancements in healthcare infrastructure. As conditions like diabetes, cancer, and cardiovascular diseases gain prominence in the region, the appetite for home-based treatment solutions intensifies.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing hospital acquired infections
  - 3.2.1.2 Rising prevalence of chronic diseases
  - 3.2.1.3 Advancements in technology
  - 3.2.1.4 Growing geriatric population
  - 3.2.1.5 Increasing preference towards at-home healthcare solutions
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Dearth of reimbursement
  - 3.2.2.2 Safety concerns and risk of failure associated with home infusion devices
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Trends in home infusion therapy industry
3.6 Gap analysis
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Future prospects for home infusion therapy industry

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Infusion pumps
5.3 Intravenous sets
5.4 IV cannulas
5.5 Needleless connectors

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Anti-infective
6.3 Hydration therapy
6.4 Chemotherapy
6.5 Enteral nutrition
6.6 Parenteral nutrition
6.7 Specialty pharmaceuticals
6.8 Other applications

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
- 7.3.7 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa